Stock Report

Venus Remedies consolidated Q4FY22 PAT slumps to Rs. 23.2 lakhs



Posted On : 2022-05-29 15:15:32( TIMEZONE : IST )

Venus Remedies consolidated Q4FY22 PAT slumps to Rs. 23.2 lakhs

Venus Remedies Limited has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 144.184 crores during the period ended March 31, 2022 as compared to Rs. 125.560 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 0.232 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 5.646 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 0.17 for the period ended March 31, 2022 as compared to Rs. 4.22 for the period ended December 31, 2021.

Financials Q4 FY2022 Q3 FY2022 % Change
Total Income ₹ 144.184 crs ₹125.560 crs Up Tick / Down Tick14.83%
Net Profit ₹0.232 crs ₹5.646 crs Up Tick / Down Tick-95.89%
EPS ₹0.17 ₹4.22 Up Tick / Down Tick-95.97%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 144.184 crores during the period ended March 31, 2022 as compared to Rs.114.863 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.232 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.35.110 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.0.17 for the period ended March 31, 2022 as compared to Rs.28.45 for the period ended March 31, 2021.

Financials Q4 FY2022 Q4 FY2021 % Change
Total Income ₹ 144.184 crs ₹114.863 crs Up Tick / Down Tick25.53%
Net Profit ₹0.232 crs ₹35.110 crs Up Tick / Down Tick-99.34%
EPS ₹0.17 ₹28.45 Up Tick / Down Tick-99.40%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.606.959 crores during the Financial Year ended March 31, 2022 as compared to Rs.567.753 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.40.724 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.61.765 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.30.86 for the Financial Year ended March 31, 2022 as compared to Rs.50.04 for the Financial Year ended March 31, 2021.

Financials Year Ended FY2022 Year Ended FY2021 % Change
Total Income ₹606.959 crs ₹567.753 crs Up Tick / Down Tick6.91%
Net Profit ₹40.724 crs ₹61.765 crs Up Tick / Down Tick-34.07%
EPS ₹30.86 ₹50.04 Up Tick / Down Tick-38.33%

Shares of Venus Remedies Limited was last trading in BSE at Rs. 221.85 as compared to the previous close of Rs. 217.75. The total number of shares traded during the day was 5126 in over 595 trades.

The stock hit an intraday high of Rs. 228.10 and intraday low of 216.05. The net turnover during the day was Rs. 1140870.00.

Source : Equity Bulls

Keywords

VenusRemedies Q4FY22 FY2022 ResultUpdate